3 test combo to treat AD?

Share this article:

Combining diagnostic tests that include imaging and cerebrospinal fluid biomarkers can improve prediction of a patient progressing from mild cognitive impairment to Alzheimer's disease, according to a study published Dec. 11 in Radiology.

Duke Medicine researchers reviewed three tests — magnetic resonance imaging (MRI), fluorine 18 fluorodeoxyglucose positron emission tomography (FDG-PET), and cerebrospinal fluid analysis — to learn whether the trio were more accurate than single tests. The study subjects also were given routine clinical exams.

Share this article:
close

Next Article in News

More in News

Assisted living communities continue to make a terrible first impression on prospective customers, university program finds

Assisted living communities continue to make a terrible ...

Assisted living communities consistently do not make a good first impression with prospective customers, and they haven't improved this skill set in the last decade, according to data from George ...

Latecomers to hospice frequently are male, have certain cancers, Penn researchers find

Men and patients with certain types of cancer are among those less likely to enroll in hospice, suggesting that healthcare providers should focus on presenting these groups with all their end-of-life care options, according to newly published findings.

Nursing homes should think twice before using a well-known tool for diagnosing ...

A familiar tool for diagnosing depression in dementia patients might not be very effective in the nursing home setting, according to findings recently published in The American Journal of Geriatric Psychiatry.